PillRx only · Solution · Intravenous
Ibuprofen Lysine
Brands: Neoprofen · Ibuprofen Lysine
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| XGen Pharmaceuticals DJB, Inc. | unknown | 1 | SUPPLYING |
| Prasco Laboratories | unknown | 1 | SUPPLYING |
| Recordati Rare Diseases, Inc. | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Feb 8, 2017RECALLRecall (Class I): Ibuprofen Lysine Injection, 20 mg/2 mL (10 mg/mL), 2 mL Single-Dose Vial (NDC 39822-1030-1), packaged in 3 x 2 mL Singl…
Presence of Particulate Matter — Recalling firm: X-Gen Pharmaceuticals Inc. — Nationwide in the USA.